The Tesla Shock Nobody Sees Coming

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

What's Going On With AI tokens?

Mark de Wolf
September 19, 2025

Crypto thrives on fads. Each fresh technology – NFTs, SocialFi, metaverse tokens – sparks furious rallies, only to see them slump when reality bites. This year's craze has been "DeFAI": artificial-intelligence agents designed to navigate decentralized finance.

In January, names like Virtuals and Ai16z sent tokens soaring. At one point the market value of AI-agent coins neared $16bn. Eight months later, they have shed nearly a third of their worth, even as Wall Street hits records on the back of AI-infrastructure spending. To many observers, the episode looks like another bout of speculative self-delusion. Yet it may also be a prelude to something more lasting.

White-labelled and re-skinned

The first generation of DeFAI projects promised sweeping automation. Platforms such as Virtuals' G.A.M.E. or Ai16z's ElizaOS made it easier to spin up tokenized agents able, in theory, to trade, lend or invest on behalf of their owners. Launchpads like DAOS.fun dangled visions of decentralized hedge funds: investors would pool cash, agents would manage it, and profits would flow back to token holders.

The idea was exciting. For little more than a few clicks, one could dispatch tireless digital workers to scour markets and place bets round the clock. An April survey by CoinGecko found that half of respondents believed AI would outperform humans at trading; one in seven was willing to hand over their portfolio entirely.

Reality proved more prosaic. Most offerings turned out to be thin wrappers around generic large-language models. Grand roadmaps led mainly to chatbots on Telegram or Discord. Tokens collapsed by over 90% from their December peak, and many treasuries soon ran dry. As in past crypto busts, investors discovered that clever tokenomics could not make up for missing utility.

Agents of change

The second wave of projects has adopted a more modest, and arguably more promising, approach. Instead of "do-it-all" bots, they focus on specialized tools that can work together.

Wayfinder exemplifies the shift. Its agents handle specific on-chain tasks--from cross-chain swaps to more elaborate strategies such as leveraged dollar-cost averaging--using embedded wallets. The system resembles a hive, each agent focused on a narrow role but orchestrated towards a wider goal.

HeyAnon takes a retail-friendly tack. Users can instruct it by voice ("Sell 0.2 ETH on Coinbase") and it will carry out the trade. That lowers the technical barrier that keeps many newcomers from experimenting with DeFi.

Virtuals Protocol aims to build standards for agent-to-agent commerce. Its Agent Commerce Protocol (ACP) would let bots communicate and delegate, multiplying their capabilities. The vision is less of a solitary super-agent and more of an agentic members club: specialized, collaborative, and self-improving with experience.

The promise, and the pitfalls

The potential prize is worth fighting for. Bitwise, a crypto asset manager, reckons that blending AI and blockchain could add $20trn to global GDP by 2030. In the near term, advocates point to agent-to-agent commerce as the most enticing application. Imagine an investment agent hiring a data-analysis agent, which in turn consults a risk-model agent before deciding whether to place a trade--all continuously, cheaply and without human oversight.

Such visions raise thorny questions. How much autonomy should these bots wield? Who ensures they follow financial regulations? How can digital assets entrusted to them be safeguarded? Without credible standards of trust, security and compliance, DeFAI's latest iteration could go the way of its predecessors.

The take away

Crypto has heard this song before. Smart contracts were once dismissed as arcane playthings; decentralized exchanges as impenetrable. Both are now pillars of DeFi. Early manias often mask genuine breakthroughs, their utility revealed only after the froth subsides.

DeFAI's evolving story is scarcely eight months old. Act one was defined by overblown ambition; act two is more practical, with agents honing in on specific tasks and working in concert. Whether they evolve into reliable robo-managers or fade into the compost heap of past crypto fads will depend less on hype than on whether they can solve real problems at scale.

For now, DeFAI's flame is flickering. But it may yet kindle something more enduring.

Benzinga Disclaimer: This article is from an unpaid external contributor. It does not represent Benzinga’s reporting and has not been edited for content or accuracy.

Continue Reading...

Popular

The White House says it blocked US Steel's decision to stop processing steel at Illinois plant

HARRISBURG, Pa. (AP) — The White House said Monday that it intervened under the terms of a three-month-old national security agreement with Japan-based Nippon Steel to block a decision to stop processing raw steel at U.S. Steel's Granite City Works plant in Illinois.

FBI Director Kash Patel Bought 2 Stocks In 2025 — One's Already A Meme Favorite

FBI Director Kash Patel was asked about two stocks he bought earlier this year by a member of Congress on Wednesday and gave a surprising answer. The transactions come as members of Congress are working on legislation to ban lawmakers and cabinet members from buying and selling stocks.

Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad

This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.

Donald Trump's Approval Rating Crashes to Record Low — Here's What's Driving the Decline

According to the recent YouGov/Economist poll, President Trump's approval rating has taken a nosedive, reaching its lowest point in his second term.

What to know about Brendan Carr, the head of the Federal Communications Commission

WASHINGTON (AP) — ABC took comic Jimmy Kimmel's off the air indefinitely Wednesday, just hours after Federal Communications Commission chairman Brendan Carr called his comments about Charlie Kirk's assassination “truly sick.”

Gold Is Being Reintroduced Into the Monetary System - Ad

While the media focuses on political scandals, inflation and coming up with ridiculous acronyms "TACO"... Smart money is tracking a far bigger shift: a gold revaluation is quietly underway. Garrett Goggin, CFA, says this could trigger 100X moves in select miners - and he's identified four with the biggest upside.

Trump Puts Taiwan Weapons Package on Ice Amid China Talks: Report

Trump has reportedly paused over $400M in Taiwan military aid as he courts China for trade talks and a potential Xi summit.

3 Gold Mining Stocks Shine As Prices Hit Records

Gold mining stocks Anglogold Ashanti, Coeur Mining, and New Gold join the top 10% for quality as gold prices hit fresh highs.

[Revealed] Trump's Next AI Executive Orders? - Ad

A White House insider with direct ties to Trump's inner circle just revealed what he calls "Manhattan II" - a potential $2.2 trillion AI initiative set to launch as soon as Oct 15. He says this could mirror past U.S. projects that minted fortunes - with small firms soaring 5,000% to 10,000% over two decades. And now he's giving away his #1 stock pick for free before the deadline.

America Has A New No. 1 Beer — And It's Got Bud Light DNA

When it comes to beer in the United States, there's a new bestselling brand.

Nio, Rivian, Moderna, Meta And Bitmine Immersion: Why These 5 Stocks Are On Investors' Radars Today

On Tuesday, U.S. markets slipped, with the Dow Jones Industrial Average falling about 0.3% to 45,757.90, the S&P 500 retreating 0.1% to 6,606.76, and the Nasdaq edging down 0.07% to 22,333.96.These are the top stocks that gained the attention of retail traders and investors throughout the day.

Nvidia Is About to Shock the World: October 23rd - Ad

Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%, is warning everyone to... Mark this date on your calendar: October 23rd! That's when Nvidia could help send shares of this Elon Musk supplier skyrocketing higher.

US To Impose $100,000 Annual Fee On H-1B Visas As Analysts Warn Trump Risks 'Taxing Away' America's Innovation Edge

The Trump administration's plan to impose a $100,000 annual fee on H-1B visas could reshape tech hiring, strain talent pipelines from India and China, and risk driving innovation overseas, analysts warn.

It's 'do or die' for electric vehicle maker Rivian as it breaks ground on a $5 billion plant

ATLANTA (AP) — It seems like a terrible time to build an electric vehicle plant in the United States, but Rivian Automotive leaders say they're confident as the company starts on a $5 billion facility in Georgia.

New Biotech Offering Targets $426B Rare Disease Market - Ad

The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.

Johnson & Johnson's Tecvayli-Darzalex Combo Shows 100% Response In Newly Diagnosed Myeloma Patients

Johnson & Johnson's Tecvayli-Darzalex regimen showed 100% response rates and high MRD negativity in newly diagnosed multiple myeloma patients.

Mortgage Bankers Association Voices Concerns With Trump's Plans For Fannie Mae, Freddie Mac Merger

MBA warns against potential Fannie Mae and Freddie Mac merger, saying it could create a government-conferred monopoly and hinder competition.

Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad

A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.

FDA takes aim at Hims and other telehealth services in drug advertising blitz

WASHINGTON (AP) — For the first time, federal health officials are taking aim at promoting unofficial versions of prescription drugs — including popular weight loss medications — as part of the on pharmaceutical advertising.

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

How 4 key infrastructure projects centered in Italy will reshape the European travel map

MILAN (AP) — Workers will begin drilling and blasting open the first tunnel connecting Austria to Italy under the Brenner Pass through the Alps on Thursday, marking a major milestone in a series of ambitious European Union projects that will accelerate passenger train travel between metropolitan centers and shift freight off the roads and onto rails.

New York City's Wealthiest Neighborhoods Witness 60% Rent Surge Since Pandemic

House rental rates in some of the wealthiest neighborhoods of New York City have surged by over 60% since the COVID-19 pandemic began, putting even high-income earners in a tight spot.

The "Mar-A-Lago Accord" Is Now Underway - Ad

The global order is in chaos. And according to 40-year market veteran Dr. David Eifrig, the biggest controlled demolition of the old monetary order in history could now be here, too. That means if you don't take action today, your wealth could decline by 40%... (Yes, even your cash savings.)

Hillary Clinton Says Trump Administration Is 'Going Great' For The President, Dogecoin Rallies 20%, Silver Token Tops Bitcoin — This Week In Crypto

The past week has been a rollercoaster ride in the world of finance and politics. From silver-backed cryptocurrencies outperforming Bitcoin (CRYPTO: BTC) to Hillary Clinton’s accusations of crypto corruption against the Trump administration, there’s been no shortage of headlines.

Trump Admin Pushes G7, EU To Slap Tariffs On China And India Over Russian Oil Purchase To 'End The Senseless Killing' In Ukraine

The U.S. is pressing G7 and EU allies to impose tariffs on China and India for buying Russian oil, while Trump's trade war policies have driven tariff revenues to a record $30 billion in August.

Another Gold High? Here's the Move Wall Street Is Missing ... - Ad

Gold just surged past $3,600, up 45% in a year - but Sean Brodrick says $6,900 could be next. History shows when gold booms, one hidden play has delivered far bigger gains - 21x, 49x, even 1,386x. The same strategy once handed 26,000% profits. And Sean says it's back on the table now.

Oracle's Big AI Bet Faces Credit Risk, Rating Agency Warns

Oracle (NYSE: ORCL) stock rises as AI deals boost investor confidence. However, Moody's warns of risks in $300B AI contracts with OpenAI.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Intel, Fedex, Lennar, Brera Holdings And Rivian: Why These 5 Stocks Are On Investors' Radars Today

U.S. stocks closed higher on Thursday, with the Dow Jones Industrial Average up 0.3% at 46,142.42. The S&P 500 advanced 0.5% to 6,631.96, while the Nasdaq climbed nearly 1% to 22,470.73.These are the top stocks that gained the attention of retail traders and investors through the day:

Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad

This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.

Tennessee Governor Deploying Federal Agents and National Guard to Memphis

Tennessee will surge federal agents, deputized Guard, and $100M in support to Memphis, launching a multi-agency task force to combat violent crime.

Gold Is Being Reintroduced Into the Monetary System - Ad

While the media focuses on political scandals, inflation and coming up with ridiculous acronyms "TACO"... Smart money is tracking a far bigger shift: a gold revaluation is quietly underway. Garrett Goggin, CFA, says this could trigger 100X moves in select miners - and he's identified four with the biggest upside.

Warner Bros Discovery Soars 9% After Hours: Here Is Why The Stock Is Trending

Warner Bros. Discovery's stock soared to a record high amid takeover talks with Paramount Skydance, reflecting strong market momentum and significant gains this year.

[Revealed] Trump's Next AI Executive Orders? - Ad

A White House insider with direct ties to Trump's inner circle just revealed what he calls "Manhattan II" - a potential $2.2 trillion AI initiative set to launch as soon as Oct 15. He says this could mirror past U.S. projects that minted fortunes - with small firms soaring 5,000% to 10,000% over two decades. And now he's giving away his #1 stock pick for free before the deadline.

US Farmers Head To China As Trade Strains Weigh: Report

U.S. farmers plan a November mission to China, seeking to revive agricultural trade as tensions strain commodity flows.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright activatrade.ca
Privacy Policy | Terms of Service